메뉴 건너뛰기




Volumn 43, Issue 5, 2002, Pages 1001-1006

Minimal residual disease in early phase of chemotherapy reflects poor outcome in children with acute lymphoblastic leukemia - A retrospective study by the Children's Cancer and Leukemia Study Group in Japan

(21)  Okamoto, Tomomi a   Yokota, Shouhei a   Katano, Naoyuki b   Seriu, Taku a   Nakao, Makoto a   Taniwaki, Masafumi a   Watanabe, Arata c   Asami, Keiko d   Kikuta, Atsushi e   Koizumi, Shoichi f   Kawakami, Tetsuo g   Ohta, Shigeru h   Miyake, Munenori i   Watanabe, Tsutomu j   Iwai, Asayuki k   Kamitamari, Akira l   Ijichi, Osamu m   Hyakuna, Nobuyuki n   Mimaya, Junichi o   Fujimoto, Takeo b   more..


Author keywords

Acute lymphoblastic leukemia (ALL); Childhood leukemia; Immunoglobulin gene; Minimal residual disease (MRD); T cell receptor gene

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; IMMUNOGLOBULIN KAPPA CHAIN; MERCAPTOPURINE; METHOTREXATE; PIRARUBICIN; PREDNISOLONE; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; VINCRISTINE;

EID: 0036241209     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190290021641     Document Type: Article
Times cited : (8)

References (31)
  • 2
    • 0032443081 scopus 로고    scopus 로고
    • "Recent advances in the biology and treatment of childhood acute lymphoblastic leukemia"
    • (1998) Curr. Opin. Hematol , vol.5 , pp. 292-301
    • Pui, C.H.1
  • 13
    • 0024438573 scopus 로고
    • "Detection of minimal residual disease in acute lymphoblastic leukemia by in vitro amplification of rearranged T-cell receptor delta chain sequences"
    • (1989) Blood , vol.74 , pp. 1762-1767
    • Hansen-Hagge, T.E.1    Yokota, S.2    Bartram, C.R.3
  • 17


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.